- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Astrazeneca Regulatory News (AZN)
Regulatory News for Astrazeneca (AZN)
| Share Price: 3,357.50 | Bid: 3,357.50 | Ask: 3,359.00 | Change: -33.00 (-0.97%) |  | ||||||
| ||||||||||
Transaction in Own Shares
Tue, 20th Sep 2011 07:00
RNS Number : 5207O
AstraZeneca PLC
20 September 2011
?
REPURCHASE OF SHARES IN ASTRAZENECA PLC
AstraZeneca PLC announced that, on 19 September 2011, it purchased for cancellation 850,000 ordinary shares of AstraZeneca PLC at a price of 2804 pence per share. Upon the cancellation of these shares, the number of shares in issue will be 1,335,501,502.
A C N Kemp
Company Secretary
20 September 2011
This information is provided by RNS
The company news service from the London Stock Exchange
| Date | Source | Headline | Category |
|---|---|---|---|
| 14-May-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 08-May-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 08-May-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 02-May-13 13:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 01-May-13 15:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 01-May-13 14:00 | RNS | Total Voting Rights | Holding(s) in Company |
| 29-Apr-13 15:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 29-Apr-13 15:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 25-Apr-13 17:50 | RNS | Result of AGM | Results and Trading Reports |
| 25-Apr-13 07:00 | RNS | 1st Quarter Results | Results and Trading Reports |
| 24-Apr-13 09:00 | RNS | Notice of Results | Advance Notice of Results |
| 05-Apr-13 07:00 | RNS | Top-line results from OSKIRA-1 phase III study | Company Announcement - General |
| 03-Apr-13 16:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 03-Apr-13 16:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 02-Apr-13 16:00 | RNS | Total Voting Rights | Holding(s) in Company |
| 02-Apr-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 02-Apr-13 07:00 | RNS | US court says one PULMICORT patent invalid | Company Announcement - General |
| 27-Mar-13 14:30 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 27-Mar-13 14:30 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 26-Mar-13 15:13 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 26-Mar-13 07:00 | RNS | Filing of Annual Report on Form 20-F with SEC | Results and Trading Reports |
| 25-Mar-13 11:38 | RNS | Annual Financial Report | Results and Trading Reports |
| 25-Mar-13 07:00 | RNS | AstraZeneca settles over Crestor patent | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | AstraZeneca announces agreement with Moderna | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | AstraZeneca partners Karolinska Institute | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | AstraZeneca outlines growth strategy | Company Announcement - General |
| 18-Mar-13 13:00 | RNS | AstraZeneca to establish strategic R&D centres | Company Announcement - General |
| 14-Mar-13 10:00 | RNS | Block Listing Application | Company Announcement - General |
| 05-Mar-13 07:00 | RNS | Australian court holds crestor patents invalid | Company Announcement - General |
| 01-Mar-13 16:00 | RNS | Total Voting Rights | Holding(s) in Company |
Regulatory news is displayed end of day, each day at 19:00.
